Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation
Authors:
- Merve AbayMAMerve Abay
- Levent OzgenLOLevent Ozgen
- 10 August 2023
- journal article
- research article
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 52 (8) , 102642
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive reviewGynecologic Oncology, 2015
- Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre studyBMC Cancer, 2015
- Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriersGynecologic Oncology, 2014
- Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC)International Journal of Gynecological Cancer, 2013
- Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomyGynecologic Oncology, 2013
- Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation CarriersInternational Journal of Gynecological Cancer, 2011
- Hereditary ovarian cancerCritical Reviews in Oncology/Hematology, 2009
- Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆Gynecologic Oncology, 2007
- Oral Contraceptives and the Risk of Hereditary Ovarian CancerNew England Journal of Medicine, 1998
- The epidemiology of ovarian cancerJournal of Cellular Biochemistry, 1995